Higashi K, Tsukiyama-Kohara K, Tanaka T, Tanaka E, Kiyosawa K, Kohara M
Department of Microbiology and Cell Biology, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Arch Virol. 2005 May;150(5):883-98. doi: 10.1007/s00705-004-0470-0. Epub 2005 Jan 19.
Hepatitis C virus (HCV) causes persistent infection in most patients. To clarify the mechanisms underlying establishment of this persistent infection, nucleotide sequences of the E1/E2 region were characterized in 5 patients with acute and chronic HCV infection. We used direct DNA sequencing methods to identify the major sequence of HCV in each patient. Each HCV genome displayed a high frequency of nucleotide sequence variation in the hypervariable region (HVR) of E2. However, patient-specific conserved nucleotide sequences were identified in the E1/E2 region during the course of infection and conserved the higher-order protein structure. In the acute phase HCV infection, amino acid substitution in HVR-1 as the monthly rate of amino acids substitution per site (%) between each point exceeded 10.2%. In the chronic phase HCV infection, a significantly lower rate of amino acid substitution was observed in patients. The host immune responses to HVR-1 of each HCV isolates from all clinical courses were characterized using synthetic peptides and ELISA. One chronic patient serum (genotype 1b) did not react at all to its own HVR-1 peptides, however another patient (genotype 2b) reacted to all clinical course. These results indicated that HVR-1 might not always exhibit neutralizing epitopes of HCV infection. The sequence variation in HVR-1 may instead indicate the existence of various clones in acute phase infection and the adaption of these clones is thought to have caused persistent and chronic infection in each patient.
丙型肝炎病毒(HCV)在大多数患者中会引发持续感染。为了阐明这种持续感染建立的潜在机制,我们对5例急性和慢性HCV感染患者的E1/E2区域核苷酸序列进行了特征分析。我们采用直接DNA测序方法来确定每位患者中HCV的主要序列。每个HCV基因组在E2高变区(HVR)均呈现出高频的核苷酸序列变异。然而,在感染过程中,E1/E2区域鉴定出了患者特异性的保守核苷酸序列,且这些序列保留了高级蛋白质结构。在急性HCV感染期,HVR-1中的氨基酸替换率,即每个位点每月氨基酸替换的百分比,在各时间点之间超过了10.2%。在慢性HCV感染期,患者中观察到的氨基酸替换率显著降低。我们使用合成肽和酶联免疫吸附测定(ELISA)对所有临床病程中分离出的每种HCV毒株的HVR-1的宿主免疫反应进行了特征分析。一名慢性患者血清(基因型1b)对其自身的HVR-1肽完全无反应,然而另一名患者(基因型2b)对所有临床病程的肽均有反应。这些结果表明,HVR-1可能并不总是表现出HCV感染的中和表位。相反,HVR-1中的序列变异可能表明在急性期感染中存在各种克隆,并且这些克隆的适应性被认为导致了每位患者的持续和慢性感染。